- Date : 04/08/2023
- Read: 3 mins
SEBI approves the IPO launch for Mamaearth, Indegene, and Vishnu Prakash R Punglia, offering shares worth Rs 400 crores, Rs 950 crores, and 3.12 crores respectively.
In a major development for the Indian capital markets, the Securities and Exchange Board of India (SEBI) has given a green flag to three companies—Honasa Consumer Limited, Indegene Limited, and Vishnu Prakash R Punglia Limited—to proceed with their Initial Public Offerings (IPOs). This comes as a positive signal for investors and marks a significant step in the companies' growth journey.
- SEBI grants the green signal to Mamaearth, Indegene, and Vishnu Prakash R Punglia's IPOs.
- Mamaearth's IPO: Rs 400 crore fresh issue, top digital-first beauty company.
- Indegene's IPO: Rs 950 crore fresh issue, strong global life sciences presence.
- Vishnu Prakash R Punglia's IPO: Rs 300 crore fresh issue, infrastructure projects focus.
Mamaearth's Digital-First Beauty and Personal Care IPO
Leading the pack is Honasa Consumer Limited, the parent company of the reknowed FMCG brands Mamaearth and The Derma Co. With the green signal from SEBI, the company's IPO will comprise Rs 400 crore as a fresh issue of equity shares and up to 4.68 crore shares through Offer For Sale (OFS) by promoters and existing shareholders.
The offering presents an opportunity for investors to become part of the largest digital-first beauty and personal care company in India, which claims the top spot in terms of revenue from operations for FY22. Mamaearth's impressive portfolio, which includes successful brands like Aqualogica, Ayuga, BBlunt, and Dr Sheth’s, adds to the appeal of the IPO.
Also Read - SBFC Finance IPO Opens Tomorrow: 5 Facts To Know About The Offer
Indegene's Healthcare Tech IPO
Indegene Limited, a life sciences commercialisation company, has also received a regulatory nod from SEBI for its IPO. The IPO offers equity shares valued at Rs 950 crore through a fresh issue and an OFS of up to 36.3 million shares by existing investors.
With client relationships among the top 20 largest biopharmaceutical companies in the world, Indegene has positioned itself as a key player in the global life sciences industry. The funds raised through the IPO are estimated to be substantial, potentially reaching Rs 3,200 crore, which could drive the company's growth and expansion plans.
Vishnu Prakash R Punglia Limited - EPC Company
Joining the IPO bandwagon is engineering, procurement, and construction (EPC) firm Vishnu Prakash R Punglia Limited. The company's IPO is offering 3.12 crore equity shares through fresh issue to focused on funding the purchase of equipment/machinery, working capital requirements, and general corporate purposes.
Vishnu Prakash R Punglia Limited's core business operations in water supply, railway projects, road projects, and irrigation networks make it a crucial player in infrastructure development. The anticipated size of Vishnu Prakash R Punglia Limited's IPO is approximately Rs 300 crore.
Find the latest articles on stocks here.
Also Read - Big Names Enter The Market: SBFC Finance, NSDL, Tata Technologies, And More With Upcoming IPOs In India 2023
Disclaimer: This article is intended for general information purposes only and should not be construed as investment or legal advice. You should separately obtain independent advice when making decisions in these areas.
